1VAHANIAN A, PALACIOS I F. Percutaneousapproaches to valvular disease[J]. Circulation, 2004, 109:1572-1579.
2ANDERSEN H R, KRNZDSEN L L, HASENKARN J M. Thansluminal irnplantation of artificial heart valves: description of a new expandable aortic valve and iniitial results with implantation by catheter technique in closed chest pigs[J]. Eur Heart J, 1992, 13: 704-708.
4CRIBIER A, ELTCHANINOFF H, TRON C, et al. Treatment of calcific aorta stenosis with the percutaneous heart valve midterm follow-up from the initial fasibility studies the French experience[J]. J Am Coll Cardiol, 2006, 47:1214-1223.
5FERRARI M, FIGULLA H R, SCHLOSSER M L, et al. Transarterial aortic valve replacement with a self expanging stent in pigs[J]. Heart, 2004, 90: 1326-1331.
6BERRY C, ASGAR A, LAMARCHE Y, et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve revalving system[J]. Catheter Cardiovasc Interv, 2007, 70: 610- 616.
7GRUBE E, LABORDE J C, ZIDANANN B, et al. First report on a human percutaneous transluninal trans transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis[J]. Catheter Cardiovasc Interv, 2005, 66:465-469.
8ROUTLEDGE H C, LEFEVRE T, MORICE M C. Percutaneous aortic valve replacement: new hope for inoperable and high-risk patients[J]. J Invasive Cardiol, 2007, 19:478-483.
9BERNARD Y, ETIEVENT J, MOURAND J L, et al. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old[J]. J Am Coll Cardiol, 1992, 20:796-801.
10GRUBE E, SCHULER G, BUELLESFELD L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome[J]. J Am Coll Cardiol, 2007, 50:69-76.
